Cargando…
CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
SIMPLE SUMMARY: Currently, breast cancer diagnostics do not have readily available diagnostic and prognostic tools, especially in the early stages of the disease. Therefore, there is a constant need to search for tumor markers that can improve current diagnostics. One such molecule that may be a pot...
Autores principales: | Motyka, Joanna, Kicman, Aleksandra, Kulesza, Monika, Ławicki, Sławomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296565/ https://www.ncbi.nlm.nih.gov/pubmed/37370728 http://dx.doi.org/10.3390/cancers15123118 |
Ejemplares similares
-
Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2022) -
Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
por: Kicman, Aleksandra, et al.
Publicado: (2022) -
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023) -
ELR+ CXC chemokine expression in benign and malignant colorectal conditions
por: Rubie, Claudia, et al.
Publicado: (2008) -
Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)